Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses 814.7 M802.78 M 3.46 B Research & development —— — Operating income 448.26 M379.64 M 1.61 B Non-Operating Income, Total —— — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses —— — Unusual income/expense —— — Pretax income 447.33 M373.88 M 1.6 B Equity in earnings -1.58 M-2.07 M -6.28 M Taxes 106.86 M91.88 M 388.17 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 340.47 M282.01 M 1.21 B Discontinued operations —— — Net income 340.47 M282.01 M 1.21 B Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 340.47 M282.01 M 1.21 B Basic earnings per share (Basic EPS) 7.786.57 27.55 Diluted earnings per share (Diluted EPS) 7.746.55 27.45 Average basic shares outstanding 43.78 M42.95 M — Diluted shares outstanding 43.96 M43.06 M — EBITDA 1.34 B457.24 M 3.53 B EBIT 1.26 B375.92 M 3.21 B Cost of revenue 1.9 B1.85 B 7.86 B Other cost of goods sold —— — Depreciation & amortization (cash flow) 81.4 M81.33 M 320.3 M